Skip to Content

News Releases

News Releases

Date Title and Summary
Toggle Summary BioScrip to Participate in Upcoming Investor Conferences
DENVER , Sept. 05, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, will participate in
Toggle Summary BioScrip Reports Second Quarter 2018 Financial Results
DENVER , Aug. 07, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ: BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its second quarter 2018 financial results.
Toggle Summary BioScrip Appoints Leslie McIntosh as Chief Human Resources Officer
DENVER , July 30, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced the appointment of Leslie McIntosh as Senior Vice President, Chief Human Resources Officer
Toggle Summary BioScrip to Present at the 38th Annual Canaccord Genuity Growth Conference
DENVER , July 23, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen M.
Toggle Summary BioScrip Schedules Release of Second Quarter 2018 Financial Results and Conference Call
DENVER , July 18, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will issue its financial results press release for the second quarter
Toggle Summary BioScrip Appoints Richard Denness as Chief Commercial Officer
DENVER , July 10, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced the appointment of Richard Denness as Senior Vice President, Chief Commercial Officer of
Toggle Summary BioScrip to Participate in Upcoming Investor Conferences
DENVER , May 16, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that Daniel E. Greenleaf , President and Chief Executive Officer, and Stephen M.
Toggle Summary BioScrip Reports First Quarter 2018 Financial Results
DENVER , May 10, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced its first quarter 2018 financial results. First Quarter 2018 Highlights Net revenue of
Toggle Summary BioScrip Schedules Release of First Quarter 2018 Financial Results and Conference Call
DENVER , April 26, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company will issue its financial results press release for the first quarter
Toggle Summary BioScrip Timely Files Annual Form 10-K, Concludes Accounting Review and Provides Update on Immaterial Financial Statement Corrections
DENVER , March 26, 2018 (GLOBE NEWSWIRE) -- BioScrip, Inc. (NASDAQ:BIOS) ("BioScrip" or the "Company"), the largest independent national provider of infusion and home care management solutions, today announced that the Company has filed timely its Annual Report on Form 10-K for the year ended